Dare Bioscience, Inc. — Director's Dealing 2023

Jan 26, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2023-01-24

Reporting Person: Walters-Hoffert Lisa (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-24	Stock Option (right to buy)	$1.16	A	290000	Acquired	2033-01-24	Common stock (290000.0)	Direct

Footnotes

F1: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.